↓ Skip to main content

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

Overview of attention for article published in BMC Medicine, August 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
4 tweeters
facebook
2 Facebook pages
googleplus
2 Google+ users
video
1 video uploader

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
156 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Published in
BMC Medicine, August 2010
DOI 10.1186/1741-7015-8-51
Pubmed ID
Authors

Alan G Wade, Ian Ford, Gordon Crawford, Alex McConnachie, Tali Nir, Moshe Laudon, Nava Zisapel

Abstract

Melatonin is extensively used in the USA in a non-regulated manner for sleep disorders. Prolonged release melatonin (PRM) is licensed in Europe and other countries for the short term treatment of primary insomnia in patients aged 55 years and over. However, a clear definition of the target patient population and well-controlled studies of long-term efficacy and safety are lacking. It is known that melatonin production declines with age. Some young insomnia patients also may have low melatonin levels. The study investigated whether older age or low melatonin excretion is a better predictor of response to PRM, whether the efficacy observed in short-term studies is sustained during continued treatment and the long term safety of such treatment.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Spain 2 1%
Belgium 2 1%
Canada 2 1%
India 1 <1%
Sweden 1 <1%
Australia 1 <1%
Unknown 145 93%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 13%
Researcher 19 12%
Other 19 12%
Student > Master 16 10%
Student > Ph. D. Student 15 10%
Other 43 28%
Unknown 23 15%
Readers by discipline Count As %
Medicine and Dentistry 69 44%
Nursing and Health Professions 14 9%
Psychology 10 6%
Agricultural and Biological Sciences 9 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 18 12%
Unknown 30 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2021.
All research outputs
#800,483
of 16,651,312 outputs
Outputs from BMC Medicine
#638
of 2,633 outputs
Outputs of similar age
#3,964
of 95,441 outputs
Outputs of similar age from BMC Medicine
#1
of 1 outputs
Altmetric has tracked 16,651,312 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,633 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,441 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them